Logo image of BLSH

BULLISH (BLSH) Stock Fundamental Analysis

USA - NYSE:BLSH - KYG169101204 - Common Stock

57.27 USD
-1.49 (-2.54%)
Last: 10/21/2025, 5:05:00 PM
57.31 USD
+0.04 (+0.07%)
After Hours: 10/21/2025, 5:05:00 PM
Fundamental Rating

3

BLSH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 236 industry peers in the Capital Markets industry. While BLSH seems to be doing ok healthwise, there are quite some concerns on its profitability. BLSH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BLSH had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: BLSH reported negative net income in multiple years.
In the past 5 years BLSH reported 4 times negative operating cash flow.
BLSH Yearly Net Income VS EBIT VS OCF VS FCFBLSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

BLSH has a Return On Assets of 2.42%. This is comparable to the rest of the industry: BLSH outperforms 44.92% of its industry peers.
BLSH has a Return On Equity of 3.09%. This is in the lower half of the industry: BLSH underperforms 69.07% of its industry peers.
Industry RankSector Rank
ROA 2.42%
ROE 3.09%
ROIC N/A
ROA(3y)-16.69%
ROA(5y)-13.85%
ROE(3y)-40.28%
ROE(5y)-28.85%
ROIC(3y)N/A
ROIC(5y)N/A
BLSH Yearly ROA, ROE, ROICBLSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

The Profit Margin of BLSH (0.03%) is worse than 73.73% of its industry peers.
BLSH's Gross Margin of 0.04% is on the low side compared to the rest of the industry. BLSH is outperformed by 72.46% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 0.03%
GM 0.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLSH Yearly Profit, Operating, Gross MarginsBLSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for BLSH remains at a similar level compared to 1 year ago.
The debt/assets ratio for BLSH has been reduced compared to a year ago.
BLSH Yearly Shares OutstandingBLSH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M
BLSH Yearly Total Debt VS Total AssetsBLSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BLSH has an Altman-Z score of 85.19. This indicates that BLSH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BLSH (85.19) is better than 99.15% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that BLSH is not too dependend on debt financing.
BLSH has a better Debt to Equity ratio (0.22) than 74.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 85.19
ROIC/WACCN/A
WACCN/A
BLSH Yearly LT Debt VS Equity VS FCFBLSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 24.59 indicates that BLSH has no problem at all paying its short term obligations.
BLSH's Current ratio of 24.59 is amongst the best of the industry. BLSH outperforms 99.58% of its industry peers.
BLSH has a Quick Ratio of 22.75. This indicates that BLSH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 22.75, BLSH belongs to the best of the industry, outperforming 99.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 24.59
Quick Ratio 22.75
BLSH Yearly Current Assets VS Current LiabilitesBLSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

BLSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.92%.
The Revenue has grown by 114.78% in the past year. This is a very strong growth!
The Revenue has been growing by 474.20% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-93.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)114.78%
Revenue growth 3Y474.21%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

BLSH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.76% yearly.
Based on estimates for the next years, BLSH will show a very negative growth in Revenue. The Revenue will decrease by -79.13% on average per year.
EPS Next Y-49.74%
EPS Next 2Y21.14%
EPS Next 3Y24.86%
EPS Next 5Y22.76%
Revenue Next Year-99.89%
Revenue Next 2Y-96.17%
Revenue Next 3Y-88.06%
Revenue Next 5Y-79.13%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLSH Yearly Revenue VS EstimatesBLSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 50B 100B 150B 200B 250B
BLSH Yearly EPS VS EstimatesBLSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 108.06, which means the current valuation is very expensive for BLSH.
80.51% of the companies in the same industry are cheaper than BLSH, based on the Price/Earnings ratio.
BLSH is valuated expensively when we compare the Price/Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 73.64, the valuation of BLSH can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLSH indicates a slightly more expensive valuation: BLSH is more expensive than 74.15% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.18. BLSH is valued rather expensively when compared to this.
Industry RankSector Rank
PE 108.06
Fwd PE 73.64
BLSH Price Earnings VS Forward Price EarningsBLSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLSH Per share dataBLSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 500 1K 1.5K

4.3 Compensation for Growth

BLSH's earnings are expected to grow with 24.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.14%
EPS Next 3Y24.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLSH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BULLISH

NYSE:BLSH (10/21/2025, 5:05:00 PM)

After market: 57.31 +0.04 (+0.07%)

57.27

-1.49 (-2.54%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners68.11%
Ins Owner ChangeN/A
Market Cap8.53B
Analysts74.12
Price Target61.43 (7.26%)
Short Float %11.52%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.89%
PT rev (3m)N/A
EPS NQ rev (1m)177.91%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)23.2%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.53%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 108.06
Fwd PE 73.64
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 3.36
P/tB 3.49
EV/EBITDA N/A
EPS(TTM)0.53
EY0.93%
EPS(NY)0.78
Fwd EY1.36%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1680.11
BVpS17.04
TBVpS16.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.42%
ROE 3.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.03%
GM 0.04%
FCFM N/A
ROA(3y)-16.69%
ROA(5y)-13.85%
ROE(3y)-40.28%
ROE(5y)-28.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover77.23
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 24.59
Quick Ratio 22.75
Altman-Z 85.19
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)79.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)0%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-49.74%
EPS Next 2Y21.14%
EPS Next 3Y24.86%
EPS Next 5Y22.76%
Revenue 1Y (TTM)114.78%
Revenue growth 3Y474.21%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-99.89%
Revenue Next 2Y-96.17%
Revenue Next 3Y-88.06%
Revenue Next 5Y-79.13%
EBIT growth 1Y-38.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year210.56%
EBIT Next 3Y68.67%
EBIT Next 5Y52.07%
FCF growth 1Y64.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.33%
OCF growth 3YN/A
OCF growth 5YN/A